587 related articles for article (PubMed ID: 33384356)
1. Pfizer's vaccine raises allergy concerns.
de Vrieze J
Science; 2021 Jan; 371(6524):10-11. PubMed ID: 33384356
[No Abstract] [Full Text] [Related]
2. Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines.
Moghimi SM
Mol Ther; 2021 Mar; 29(3):898-900. PubMed ID: 33571463
[No Abstract] [Full Text] [Related]
3. Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines.
Murphy KR; Patel NC; Ein D; Hudelson M; Kodoth S; Marshall GD; Parikh P; Blaiss MS
Ann Allergy Asthma Immunol; 2021 Apr; 126(4):319-320. PubMed ID: 33493641
[No Abstract] [Full Text] [Related]
4. Nucleoside-modified messenger RNA COVID-19 vaccine platform.
Roncati L; Corsi L
J Med Virol; 2021 Jul; 93(7):4054-4057. PubMed ID: 33675239
[TBL] [Abstract][Full Text] [Related]
5. Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines.
Risma KA; Edwards KM; Hummell DS; Little FF; Norton AE; Stallings A; Wood RA; Milner JD
J Allergy Clin Immunol; 2021 Jun; 147(6):2075-2082.e2. PubMed ID: 33857566
[TBL] [Abstract][Full Text] [Related]
6. Basophil reactivity to BNT162b2 is mediated by PEGylated lipid nanoparticles in patients with PEG allergy.
Troelnikov A; Perkins G; Yuson C; Ahamdie A; Balouch S; Hurtado PR; Hissaria P
J Allergy Clin Immunol; 2021 Jul; 148(1):91-95. PubMed ID: 33991580
[TBL] [Abstract][Full Text] [Related]
7. Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit?
Garvey LH; Nasser S
Br J Anaesth; 2021 Mar; 126(3):e106-e108. PubMed ID: 33386124
[No Abstract] [Full Text] [Related]
8. mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis.
Rama TA; Moreira A; Castells M
J Allergy Clin Immunol; 2021 Mar; 147(3):877-878. PubMed ID: 33485650
[No Abstract] [Full Text] [Related]
9. Vaccination hesitancy and the "myth" on mRNA-based vaccines in Italy in the COVID-19 era: Does urgency meet major safety criteria?
Chirumbolo S
J Med Virol; 2021 Jul; 93(7):4049-4053. PubMed ID: 33666240
[TBL] [Abstract][Full Text] [Related]
10. Maintaining Safety with SARS-CoV-2 Vaccines.
Castells MC; Phillips EJ
N Engl J Med; 2021 Feb; 384(7):643-649. PubMed ID: 33378605
[No Abstract] [Full Text] [Related]
11. Experience with polyethylene glycol allergy-guided risk management for COVID-19 vaccine anaphylaxis.
Brockow K; Mathes S; Fischer J; Volc S; Darsow U; Eberlein B; Biedermann T
Allergy; 2022 Jul; 77(7):2200-2210. PubMed ID: 34806775
[TBL] [Abstract][Full Text] [Related]
12. Excipients as Potential Agents of Anaphylaxis in Vaccines: Analyzing the Formulations of Currently Authorized COVID-19 Vaccines.
Caballero ML; Quirce S
J Investig Allergol Clin Immunol; 2021 Feb; 31(1):92-93. PubMed ID: 33433387
[No Abstract] [Full Text] [Related]
13. COVID vaccines and safety: what the research says.
Remmel A
Nature; 2021 Feb; 590(7847):538-540. PubMed ID: 33597779
[No Abstract] [Full Text] [Related]
14. Polyethylene glycol and polysorbate skin testing in the evaluation of coronavirus disease 2019 vaccine reactions: Early report.
Pitlick MM; Sitek AN; Kinate SA; Joshi AY; Park MA
Ann Allergy Asthma Immunol; 2021 Jun; 126(6):735-738. PubMed ID: 33775902
[No Abstract] [Full Text] [Related]
15. Anaphylaxis and Coronavirus Disease 2019 vaccine: a danger relationship?
Tanno LK; Castells M; Caminati M; Senna G; Demoly P
Curr Opin Allergy Clin Immunol; 2021 Oct; 21(5):411-417. PubMed ID: 34334663
[TBL] [Abstract][Full Text] [Related]
16. Safe Administration of SARS-CoV-2 Vaccine After Desensitization to a Biologic Containing Polysorbate 80 in a Patient With Polyethylene Glycol-Induced Severe Anaphylaxis and Sensitization to Polysorbate 80.
Nin-Valencia A; Fiandor A; Lluch M; Quirce S; Caballero T; Heredia Revuelto R; González-Muñoz M; Caballero ML; Cabañas R
J Investig Allergol Clin Immunol; 2023 Apr; 33(2):151-153. PubMed ID: 35638393
[No Abstract] [Full Text] [Related]
17. Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients.
Rojas-Pérez-Ezquerra P; Crespo Quirós J; Tornero Molina P; Baeza Ochoa de Ocáriz ML; Zubeldia Ortuño JM
J Investig Allergol Clin Immunol; 2021 Apr; 31(2):180-181. PubMed ID: 33648905
[No Abstract] [Full Text] [Related]
18. Allergic Reactions to COVID-19 Vaccines: An Allergist's Perspective.
Cruz C; Gaspar Â; Borrego LM
Acta Med Port; 2021 Mar; 34(3):243. PubMed ID: 33547771
[No Abstract] [Full Text] [Related]
19. Delving Into COVID-19 Vaccination-Induced Anaphylaxis: Are mRNA Vaccines Safe in Mast Cell Disorders?
Azenha Rama T; Álvarez-Twose I
J Investig Allergol Clin Immunol; 2021 Apr; 31(2):193-195. PubMed ID: 33574015
[No Abstract] [Full Text] [Related]
20. Potential culprits for immediate hypersensitivity reactions to BNT162b2 mRNA COVID-19 vaccine: not just PEG.
Radice A; Fassio F; Meucci E; Iorno MCL; Macchia D
Eur Ann Allergy Clin Immunol; 2021 Sep; 53(5):240-242. PubMed ID: 33913314
[No Abstract] [Full Text] [Related]
[Next] [New Search]
